Cargando…
A deep learning ensemble approach to prioritize antiviral drugs against novel coronavirus SARS-CoV-2 for COVID-19 drug repurposing
The alarming pandemic situation of Coronavirus infectious disease COVID-19, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has become a critical threat to public health. The unexpected outbreak and unrealistic progression of COVID-19 have generated an utmost need to real...
Autores principales: | K., Deepthi, A.S., Jereesh, Liu, Yuansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492370/ https://www.ncbi.nlm.nih.gov/pubmed/34630000 http://dx.doi.org/10.1016/j.asoc.2021.107945 |
Ejemplares similares
-
Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020) -
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020) -
Prioritizing antiviral drugs against SARS-CoV-2 by integrating viral complete genome sequences and drug chemical structures
por: Peng, Lihong, et al.
Publicado: (2021) -
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020) -
What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
por: Martinez, Miguel Angel
Publicado: (2022)